IL138502A0 - Cell differentiation/ proliferation and maintenaince factor and uses thereof - Google Patents
Cell differentiation/ proliferation and maintenaince factor and uses thereofInfo
- Publication number
- IL138502A0 IL138502A0 IL13850299A IL13850299A IL138502A0 IL 138502 A0 IL138502 A0 IL 138502A0 IL 13850299 A IL13850299 A IL 13850299A IL 13850299 A IL13850299 A IL 13850299A IL 138502 A0 IL138502 A0 IL 138502A0
- Authority
- IL
- Israel
- Prior art keywords
- maintenaince
- proliferation
- factor
- cell differentiation
- differentiation
- Prior art date
Links
- 230000024245 cell differentiation Effects 0.000 title 1
- 230000004663 cell proliferation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
- C12N15/8775—Murine embryos
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/80—Neurotransmitters; Neurohormones
- C12N2501/83—Tachykinins, e.g. substance P
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/14—Coculture with; Conditioned medium produced by hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP2912A AUPP291298A0 (en) | 1998-04-09 | 1998-04-09 | Biologically active factor, uses thereof and cells derived from use thereof |
AUPP6097A AUPP609798A0 (en) | 1998-09-23 | 1998-09-23 | Biologically active factor, uses thereof and cells derived from use thereof |
PCT/AU1999/000265 WO1999053021A1 (en) | 1998-04-09 | 1999-04-09 | Cell differentiation/proliferation and maintenance factor and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL138502A0 true IL138502A0 (en) | 2001-10-31 |
Family
ID=25645753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13850299A IL138502A0 (en) | 1998-04-09 | 1999-04-09 | Cell differentiation/ proliferation and maintenaince factor and uses thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1068295A4 (en) |
JP (1) | JP2002517982A (en) |
CA (1) | CA2324591A1 (en) |
IL (1) | IL138502A0 (en) |
NZ (1) | NZ507103A (en) |
WO (1) | WO1999053021A1 (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7410798B2 (en) * | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
US10638734B2 (en) | 2004-01-05 | 2020-05-05 | Abt Holding Company | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
US8252280B1 (en) | 1999-08-05 | 2012-08-28 | Regents Of The University Of Minnesota | MAPC generation of muscle |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
CA2395714A1 (en) * | 1999-12-21 | 2001-06-28 | Takeda Chemical Industries, Ltd. | Novel tachykinin-like polypeptides and use thereof |
US20050042749A1 (en) | 2001-05-16 | 2005-02-24 | Carpenter Melissa K. | Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
US20030134413A1 (en) * | 2000-01-14 | 2003-07-17 | Rathjen Peter David | Cell production |
WO2001051610A1 (en) * | 2000-01-14 | 2001-07-19 | Bresagen Limited | Ectoderm cell production |
CN1311228A (en) * | 2000-03-02 | 2001-09-05 | 上海博德基因开发有限公司 | New polypeptide-human sperm specific protein EM1, EM6-48 and polynucleotide for coding said polypeptide |
JP2004501232A (en) | 2000-05-11 | 2004-01-15 | ザ ダウ ケミカル カンパニー | Method for producing an elastic article having improved heat resistance |
US7250294B2 (en) | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
WO2001088104A2 (en) | 2000-05-17 | 2001-11-22 | Geron Corporation | Neural progenitor cell populations |
CA2438501C (en) | 2001-02-14 | 2014-09-16 | Leo T. Furcht | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
JP2004535199A (en) * | 2001-07-12 | 2004-11-25 | ジェロン コーポレイション | Cardiomyocyte lineage cells produced from human pluripotent stem cells |
AU2002317039B2 (en) * | 2001-07-24 | 2007-10-04 | Es Cell International Pte Ltd | Methods of inducing differentiation of stem cells |
US7432104B2 (en) | 2001-08-06 | 2008-10-07 | Bresgen Inc. | Methods for the culture of human embryonic stem cells on human feeder cells |
US7445931B2 (en) | 2002-09-25 | 2008-11-04 | Bresagen, Inc. | Compositions and methods for enrichment of neural stem cells using ceramide analogs |
US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
WO2005121319A1 (en) * | 2004-06-14 | 2005-12-22 | Novathera Ltd | Methods for production of mesodermal lineage cells |
JP5102030B2 (en) | 2004-08-13 | 2012-12-19 | ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド | Compositions and methods for self-renewal and differentiation in human embryonic stem cells |
ES2800973T3 (en) * | 2004-09-28 | 2021-01-07 | Wisconsin Alumni Res Found | Primate embryonic stem cell culture |
GB2441718B (en) | 2005-06-22 | 2010-10-06 | Geron Corp | Differentiation of human embryonic stem cells to cardiomyocyte-lineage cells |
WO2007101130A2 (en) | 2006-02-23 | 2007-09-07 | Novocell, Inc. | Compositions and methods useful for culturing differentiable cells |
EP2087101A2 (en) | 2006-11-24 | 2009-08-12 | Regents of the University of Minnesota | Endodermal progenitor cells |
US8623650B2 (en) | 2007-10-19 | 2014-01-07 | Viacyte, Inc. | Methods and compositions for feeder-free pluripotent stem cell media containing human serum |
US9329169B2 (en) * | 2007-10-29 | 2016-05-03 | University Of Georgia Research Foundation, Inc | Vivo isotopic labeling method for quantitative glycomics |
EP2229435B1 (en) * | 2007-12-06 | 2016-03-02 | Agency for Science, Technology And Research | Method for extracellular matrix mediated differentiation and proliferation of stem cells |
US10227563B2 (en) | 2008-06-06 | 2019-03-12 | Riken | Method for culture of stem cell |
JP5390624B2 (en) | 2008-11-04 | 2014-01-15 | バイアサイト インク | Stem cell assembly suspension composition and differentiation method thereof |
US8895300B2 (en) | 2008-11-04 | 2014-11-25 | Viacyte, Inc. | Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof |
US8008075B2 (en) | 2008-11-04 | 2011-08-30 | Viacyte, Inc. | Stem cell aggregate suspension compositions and methods of differentiation thereof |
AU2009313870B2 (en) | 2008-11-14 | 2013-07-11 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
JP5115530B2 (en) * | 2009-09-18 | 2013-01-09 | ユーハ味覚糖株式会社 | A candy, gummi or beverage containing a neurogenesis-promoting agent |
US10793830B2 (en) | 2009-11-05 | 2020-10-06 | Riken | Method for producing retinal tissue in vitro |
AU2013248265B2 (en) | 2012-11-08 | 2018-11-01 | Viacyte, Inc. | Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof |
USD720469S1 (en) | 2013-03-07 | 2014-12-30 | Viacyte, Inc. | Cell encapsulation device |
EP2964147B1 (en) | 2013-03-07 | 2018-05-09 | Viacyte, Inc. | 3-dimensional large capacity cell encapsulation device assembly |
EP3290510A1 (en) * | 2016-08-31 | 2018-03-07 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Model kit for suspension cell lines |
CA3042495A1 (en) | 2016-11-10 | 2018-05-17 | Viacyte, Inc. | Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof |
EP3565890B1 (en) * | 2017-01-05 | 2023-11-01 | Agency for Science, Technology and Research | Methods of generating hepatic macrophages and uses thereof |
WO2018185260A1 (en) * | 2017-04-06 | 2018-10-11 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Novel human hepatocyte-derived matrix for stem-cell differentiation and tissue repair |
US20190167724A1 (en) * | 2017-12-04 | 2019-06-06 | Caire Medical-Biotechnology International Co. | Neuroprotective composition, preparation process thereof and medical uses thereof |
CN114807005B (en) * | 2022-04-09 | 2023-11-21 | 翌圣生物科技(上海)股份有限公司 | Method for preparing matrigel by using animal carcasses |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453357A (en) * | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US5405772A (en) * | 1993-06-18 | 1995-04-11 | Amgen Inc. | Medium for long-term proliferation and development of cells |
US6331406B1 (en) * | 1997-03-31 | 2001-12-18 | The John Hopkins University School Of Medicine | Human enbryonic germ cell and methods of use |
-
1999
- 1999-04-09 CA CA002324591A patent/CA2324591A1/en not_active Abandoned
- 1999-04-09 IL IL13850299A patent/IL138502A0/en unknown
- 1999-04-09 JP JP2000543569A patent/JP2002517982A/en not_active Withdrawn
- 1999-04-09 EP EP99914359A patent/EP1068295A4/en not_active Withdrawn
- 1999-04-09 WO PCT/AU1999/000265 patent/WO1999053021A1/en not_active Application Discontinuation
- 1999-04-09 NZ NZ507103A patent/NZ507103A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999053021A9 (en) | 2000-05-04 |
JP2002517982A (en) | 2002-06-25 |
CA2324591A1 (en) | 1999-10-21 |
WO1999053021A1 (en) | 1999-10-21 |
EP1068295A1 (en) | 2001-01-17 |
EP1068295A4 (en) | 2002-08-21 |
NZ507103A (en) | 2002-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL138502A0 (en) | Cell differentiation/ proliferation and maintenaince factor and uses thereof | |
HUP0102535A3 (en) | Cd19xcd3 specific polypeptides and uses thereof | |
IL143529A0 (en) | An electrolysis cell and methods utilizing the same | |
EP0833352A4 (en) | Solid electrolyte capacitor and its manufacture | |
HU9903361D0 (en) | Filter-device with collecting-vessel and with heating-device | |
IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
SG63814A1 (en) | Thin type cell | |
EP1021185A4 (en) | Didhydropyrimidines and uses thereof | |
EP0790826A4 (en) | Dihydropyrimidines and uses thereof | |
EP0894807A4 (en) | GPIb-LIPID COMPLEX AND USES THEREOF | |
GB9806806D0 (en) | Peptides and uses thereof | |
EP1015474A4 (en) | Don-1 gene and polypeptides and uses therefor | |
GB9816761D0 (en) | Herpesvirus preparations and their uses | |
IL130335A0 (en) | Serum-derived factor inducing cell differentiation and medical uses thereof | |
AU6230700A (en) | Cell cycle and proliferation proteins | |
GB9821193D0 (en) | Mammalian artificial chromosomes and uses thereof | |
GB0026240D0 (en) | Polymers and their uses | |
AU5875799A (en) | Mip-1alpha isoform ld78beta and uses thereof | |
EP1009047A4 (en) | Battery plate and battery | |
EP1197554A4 (en) | Proliferation differentiation factor | |
GB9810372D0 (en) | Polymers and their uses | |
EP0889953A4 (en) | Human epithelial cell matrix and uses therefor | |
GB9705744D0 (en) | Methods for selecting cells and their uses | |
EP1099755A4 (en) | Novel gene and transformant carrying the same | |
AU6160598A (en) | Differentiation enhancing factors and uses therefor |